2024-11-26 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Analysis Report

This report analyzes Colgate-Palmolive Co (CL), a leading manufacturer and distributor of consumer products, including oral care, personal care, home care, and pet nutrition products, based on the provided data.


**1. Performance vs. S&P 500 (VOO):**

Colgate-Palmolive's cumulative return of 48.34% significantly lags behind the S&P 500's (VOO) cumulative return of 128.31%.  The difference is -79.97%, placing it at the 7th percentile of its historical performance range against the S&P 500 (relative divergence of 7.0).  This indicates that CL has underperformed the market benchmark considerably over the period considered.  The provided CAGR data shows fluctuating performance relative to the S&P 500, with periods of both outperformance and underperformance.  The beta values consistently below 1 suggest lower volatility than the overall market.


**2. Recent Price Movement:**

* **Closing Price:** $95.34
* **5-Day Moving Average:** $94.41
* **20-Day Moving Average:** $93.20
* **60-Day Moving Average:** $99.14

The stock price is currently below its 5-day, 20-day, and 60-day moving averages, suggesting a downtrend.  The price is closer to its 5 and 20 day averages implying some potential for recovery but overall trend remains bearish.

**3. Technical Indicators and Expected Return:**

* **RSI (Relative Strength Index):** 53.81 -  Suggests the stock is neither overbought nor oversold, currently in neutral territory.
* **PPO (Price Oscillator):** 0.67 - A positive value indicates a bullish momentum, albeit a relatively weak one.
* **Delta_Previous_Relative_Divergence:** -0.32 - Indicates a recent short-term downward trend in relative performance compared to the S&P 500.
* **Expected Return:** 0.0% -  The provided data indicates no expected excess return compared to the S&P 500 for long-term (2+ years) investment, which aligns with the underperformance observed.  The 0% figure needs further contextualization, potentially considering a wider range of scenarios or other metrics.  Given its underperformance vs the S&P 500, it might be less likely to generate excess returns in the future, unless specific underlying business changes indicate otherwise.


**4. Recent Financial Performance and Outlook:**

The provided financial data shows relatively stable revenue figures around $5 billion per quarter, with slight fluctuations. EPS is also relatively stable, though exhibiting some slight decline recently.  More information is needed on the expected earnings, market consensus, and analyst estimates to properly assess the recent financial performance, though revenue and profit margins show reasonable consistency.

| Date       | EPS  | Revenue     |
|------------|------|-------------|
| 2024-10-25 | 0.9  | $5.03B      |
| 2024-07-26 | 0.89 | $5.06B      |
| 2024-04-26 | 0.83 | $5.07B      |
| 2023-10-27 | 0.86 | $4.92B      |
| 2023-10-25 | 0.86 | $4.92B      |


**6. Financial Statement Analysis:**

The revenue and profit margin have shown good stability and consistency over the past year. However, equity and ROE figures show significant variability, suggesting potential volatility in the company's financial position.  Further investigation is needed to understand the causes of such large swings in equity.  The negative equity number in 2023-09-30 requires special attention and clarification.


**7. News and Recent Issues:**

*(This section requires real-time data.  Please provide recent news articles from sources like Shacknews or Finbold to enable a thorough analysis.)*  I need current news and analyst opinions to complete this section.  The analysis will include a review of recent market outlook, analyst opinions, and performance highlights based on the supplied news articles.


**8. Overall Summary:**

Colgate-Palmolive (CL) has significantly underperformed the S&P 500 over the observed period. While it demonstrates consistent revenue and profit margins, its recent price action suggests a downtrend.  Technical indicators are neutral, and the expected return is currently projected at 0% relative to the S&P 500, suggesting caution. The considerable volatility in equity and ROE from the quarterly financial statements warrants deeper investigation.  A thorough analysis of recent news and analyst opinions (missing in this report due to data unavailability) is crucial for a complete investment decision.


**9. Disclaimer:** This report is for informational purposes only and does not constitute financial advice.  Investment decisions should be made based on your own research and risk tolerance.  Consult with a qualified financial advisor before making any investment decisions.
